Targeting inflammatory mediators has become a cornerstone of treating inflammatory diseases. For example, monoclonal antibodies against TNF-α (such as infliximab) are widely used in the treatment of autoimmune diseases like Crohn's disease and rheumatoid arthritis. Corticosteroids, which inhibit the production of various inflammatory mediators, are another class of anti-inflammatory drugs used in clinical practice.
